Literature DB >> 20680480

Shortening the duration of [18F]FDG PET brain examination for diagnosis of brain glioma.

Toshihide Monden1, Nobuyuki Kudomi, Yasuhiro Sasakawa, Yuka Yamamoto, Nobuyuki Kawai, Yoshihiro Nishiyama.   

Abstract

PURPOSE: Some patients cannot remain immobile for a long duration of 60 min, which is generally applied in the case of a 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) dynamic positron emission tomography (PET) scan. We investigated the change of the parametric values when the time duration of PET data was shortened. PROCEDURES: Eight normal subjects and four subjects with brain glioma were studied. The rate values of K(1), k(2), k(3), and K(i) parametric images were computed by changing the time duration from 20 to 60 min, and changes of those parametric values were compared.
RESULTS: The change was 20-30% and 3-5% for k(3) and K(i), respectively, when the scan time was shortened from 60 to 40 min. The ratios of normal and disease regions in k(3) and K(i) values were similar, and contrasts of those images were not changed when the scan time was shortened to 40 min.
CONCLUSIONS: These results demonstrate that the short time duration of [(18)F]FDG PET examination can provide an acceptable estimation of parametric k(3) and K(i) images.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20680480     DOI: 10.1007/s11307-010-0384-z

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  18 in total

1.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

2.  Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro Sasakawa; Nobuyuki Kawai; Katashi Satoh; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 9.236

3.  Evaluation of glucose transport in malignant glioma by PET.

Authors:  M Ishikawa; H Kikuchi; S Nishizawa; Y Yonekura
Journal:  Acta Neurochir Suppl (Wien)       Date:  1990

4.  FDG transport and phosphorylation in human gliomas measured with dynamic PET.

Authors:  K Herholz; J Rudolf; W D Heiss
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

5.  Short dynamic FDG-PET imaging protocol for patients with lung cancer.

Authors:  T Torizuka; S Nobezawa; S Momiki; N Kasamatsu; T Kanno; E Yoshikawa; M Futatsubashi; H Okada; Y Ouchi
Journal:  Eur J Nucl Med       Date:  2000-10

6.  Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.

Authors:  M Ishikawa; H Kikuchi; I Nagata; S Yamagata; W Taki; Y Yonekura; S Nishizawa; Y Iwasaki; T Mukai
Journal:  Neurol Med Chir (Tokyo)       Date:  1990-06       Impact factor: 1.742

7.  Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.

Authors:  D Delbeke; C Meyerowitz; R L Lapidus; R J Maciunas; M T Jennings; P L Moots; R M Kessler
Journal:  Radiology       Date:  1995-04       Impact factor: 11.105

8.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

Authors:  G Di Chiro; R L DeLaPaz; R A Brooks; L Sokoloff; P L Kornblith; B H Smith; N J Patronas; C V Kufta; R M Kessler; G S Johnston; R G Manning; A P Wolf
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

9.  18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

Authors:  Alexander M Spence; Mark Muzi; David A Mankoff; S Finbarr O'Sullivan; Jeanne M Link; Thomas K Lewellen; Barbara Lewellen; Pam Pham; Satoshi Minoshima; Kristin Swanson; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

10.  Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.

Authors:  Naruhide Kimura; Yuka Yamamoto; Reiko Kameyama; Tetsuhiro Hatakeyama; Nobuyuki Kawai; Yoshihiro Nishiyama
Journal:  Nucl Med Commun       Date:  2009-08       Impact factor: 1.690

View more
  2 in total

1.  Effect of MRI acoustic noise on cerebral fludeoxyglucose uptake in simultaneous MR-PET imaging.

Authors:  Daniel B Chonde; Nasreddin Abolmaali; Grae Arabasz; Alexander R Guimaraes; Ciprian Catana
Journal:  Invest Radiol       Date:  2013-05       Impact factor: 6.016

2.  Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.

Authors:  Milan Grkovski; Jazmin Schwartz; Mithat Gönen; Heiko Schöder; Nancy Y Lee; Sean D Carlin; Pat B Zanzonico; John L Humm; Sadek A Nehmeh
Journal:  J Nucl Med       Date:  2015-11-25       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.